Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
March 12, 2024. Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group Ltd., announced that it has received ...
On January 13, 2024, Simcere Zaiming Pharmaceutical Co. Ltd. (“Simcere Zaiming”), an innovative oncology company and a subsidiary of Simcere Pharmaceu...
On January 11, Pacific Time, Stanford University and Simcere Pharmaceutical Group Limited (Simcere; 2096.HK) entered into a collaborative research agr...
On January 4, 2024, Simcere Zaiming Pharmaceutical Co. Ltd. (“Simcere Zaiming”), an innovative oncology company and a subsidiary of Simcere Pharmaceut...